Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Papilloma × Colposcopy × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 4 Uterine Cervical Dysplasia 2 Neoplasms 2 Precancerous Conditions 1 Papilloma 1 Neoplasms, Squamous Cell 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Histologic Type 1

Interventions

Papanicolaou Test 1 Microsurgery 1 Lasers, Gas 1 Lasers, Dye 1 Laser Therapy 1 Human Papillomavirus DNA Tests 1 Colposcopy 1 Celecoxib 1 3,3'-diindolylmethane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01234480 2023-05-16

Intended Use Study of the BD SurePath Plus™ Pap

Becton, Dickinson and Company

5,859 enrolled 4 charts

Uterine Cervical Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡